NEW YORK (GenomeWeb) – Theranostics Health today announced an agreement with Avera Health to expand research and commercial collaborations on the firm's TheraLink Assay.

The proteomic panel measures the activation of several drug targets and biomarkers associated with commonly prescribed cancer therapies to monitor treatment response.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.